SiteOne Landscape Supply Earnings Perspective: Return On Invested Capital
Pulled from Benzinga Pro data, SiteOne Landscape Supply (NYSE:SITE) posted Q3 earnings of $103.40 million, an increase from Q2 of 37.18%. Sales dropped to $936.40 million, a 13.62% decrease between quarters.
RBC Capital Maintains Underperform on SiteOne Landscape Supply, Raises Price Target to $197
RBC Capital analyst Mike Dahl maintains SiteOne Landscape Supply (NYSE:SITE) with a Underperform and raises the price target from $165 to $197.
SiteOne Landscape Supply Q3 EPS $1.74 Beats $1.25 Estimate, Sales $936.40M Beat $905.63M Estimate
SiteOne Landscape Supply (NYSE:SITE) reported quarterly earnings of $1.74 per share which beat the analyst consensus estimate of $1.25 by 39.2 percent. This is a 61.11 percent increase over earnings of $1.08 per share
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
SiteOne Landscape Supply’s Earnings: A Preview
SiteOne Landscape Supply (NYSE:SITE) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement.
Analysts estimate that SiteOne Landscape Supply will likely report an Earnings Per Share (EPS) of $1.25
SiteOne Buys Green Brothers Earth Works, Southern Landscape Supply For Undisclosed Sum
SiteOne Landscape Supply Inc (NYSE:SITE) acquires Green Brothers Earth Works and Southern Landscape Supply for undisclosed financial terms. The acquisition strengthens SiteOne’s landscape supplies…
SiteOne Landscape Supply Stock Gains On Strong Q2, Raised FY21 Adjusted EBITDA Outlook
SiteOne Landscape Supply Inc (NYSE:SITE) reported a second-quarter net sales increase of 33% year-over-year to $1.084 billion, beating the consensus of…
SiteOne Landscape Supply Q2 EPS $2.70 Beats $2.37 Estimate, Sales $1.10B Beat $1.04B Estimate
SiteOne Landscape Supply (NYSE:SITE) reported quarterly earnings of $2.70 per share which beat the analyst consensus estimate of $2.37 by 13.92 percent. This is a 47.54 percent increase over earnings of $1.83 per share
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.